ClearVue Technologies, an Australian clean technology company that converts solar energy absorbed by building façades into renewable energy, has established a new global research and development ( R&D ) base in Hong Kong.
The facility, notes government agency Invest Hong Kong ( InvestHK ), will further expand to address increasing project management and business development needs in Asia, with a strategic focus on the Guangdong-Hong Kong-Macao Greater Bay Area ( GBA ).
ClearVue, the government agency notes, will continue to invest in people and infrastructure in Hong Kong as its GBA projects take shape, and use the city as a strategic gateway for further expansion across Asia-Pacific.
The cleantech, supported by InvestHK, has previously announced a joint venture in Hong Kong with mainland Chinese vacuum glass manufacturer Luoyang Landvac Ti-Vig.
Through this joint venture, the two companies will collaborate on R&D, combining ClearVue’s patented solar glass technology with mainland manufacturing strengths to produce cost-effective, energy-generating glass for buildings. Hong Kong will play a pivotal role in this new global R&D base.
“This investment perfectly illustrates Hong Kong's unique value proposition – seamlessly combining Australian frontier technology with our local R&D strengths and the robust manufacturing capabilities of the broader GBA,” says Arnold Lau, InvestHK’s acting director-general of investment promotion. “We look forward to seeing ClearVue use Hong Kong as a springboard to promote not only its innovative solutions, but also this powerful synergy across Asia and beyond.”
Doug Hunt, ClearVue’s CEO and managing director, adds: “Hong Kong brings together everything we need to accelerate our growth in Asia. Strong local demand, a deep engineering talent pool and a well-regarded construction industry make it the ideal location to develop and deliver projects.
“Through our Hong Kong joint venture, we can combine our technology with mainland manufacturing capabilities to make solar glass more cost-effective, while our R&D team benefits from easy access to rapid prototyping and testing.”
